The training and internal validation groups had no significant differences with regard to such clinicopathological characteristics as age, sex, maximum tumor size, multifocality, CLNM, LLNM, TPOAb level, BRAFV600E mutation, ETE, TSH level, and PS-Tg level. The gene discussed is TG; the disease is neoplasm.